Connect with us

Plato Vertical Search

Crowdfunding

[Alpha Tau in Yahoo Finance] Alpha Tau Receives FDA’s Breakthrough Device Designation for the Treatment of Recurrent GBM

[Alpha Tau in Yahoo Finance] Alpha Tau Receives FDA’s Breakthrough Device Designation for the Treatment of Recurrent GBM

Alpha Tau Medical, the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, is pleased to announce that it has received Breakthrough Device Designation for Alpha DaRT from the U.S. Food and Drug Administration (FDA) for the treatment of patients with recurrent glioblastoma multiforme (GBM).

Read more here.

PlatoAi. Web3 Reimagined. Data Intelligence Amplified.
Click here to access.

Source: https://blog.ourcrowd.com/alpha-tau-receives-fdas-breakthrough-device-designation-for-the-treatment-of-recurrent-gbm/

Related Streams

Blockchain

Exohood, a Decentralized Autonomous Organization, is building a new online financial platform by the end of the year. “ExoArato” is the application’s name, which will support...

Blockchain

1 of 1 #nft collectibles are now up for grabs!Continue reading on Medium »

Blockchain

The disconnect between corporate structures and blockchains is decreasing with Accumulate.Continue reading on Medium »

Blockchain

This weekend, the markets are incredibly depressing, with Bitcoin and Ethereum continuing their sharp decline. On the bright side, a recently released Web3 coin...